
Zukaria5 mg
Incepta Pharmaceuticals Ltd.
Asenapine Maleate is an atypical (second-generation) antipsychotic indicated for: Schizophrenia — treatment in adults and adolescents (10-17 years); this is an FDA-approved and more.
Asenapine Maleate is an atypical (second-generation) antipsychotic indicated for:
Asenapine Maleate is not approved for the treatment of psychosis associated with dementia (see Precautions and Warnings, boxed warning).
| Population | Recommended Dose |
|---|---|
| Adults | Initial 5 mg sublingually twice daily; may increase to 10 mg twice daily based on efficacy and tolerability. |
| Adolescents (10-17 years) | 2.5 mg sublingually twice daily; may increase to 5 mg twice daily after at least 3 days if needed and tolerated. |
| Population | Recommended Dose |
|---|---|
| Adults (monotherapy) | Initial 10 mg sublingually twice daily; may reduce to 5 mg twice daily if not tolerated. |
| Adults (adjunct to lithium or valproate) | 5 mg sublingually twice daily; may increase to 10 mg twice daily based on response. |
| Adolescents (10-17 years) | Initial 2.5 mg sublingually twice daily, may increase to 5 mg then 10 mg twice daily at intervals of at least 3 days based on response and tolerability. |
No dose adjustment of Asenapine Maleate is required in patients with any degree of renal impairment.
No dose adjustment is needed in mild (Child-Pugh A) or moderate (Child-Pugh B) hepatic impairment. Use in severe hepatic impairment (Child-Pugh C) is contraindicated (see Contraindications).
Common side effects of Asenapine Maleate include:
Less common but serious effects include neuroleptic malignant syndrome, tardive dyskinesia, orthostatic hypotension/syncope, QT prolongation, seizures, leukopenia/neutropenia, hyperprolactinemia, and metabolic changes (dyslipidemia, hyperglycemia) — see Precautions and Warnings for details.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.